Literature DB >> 20724599

Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Cristan Herbert1, Melissa M Scott, Kim H Scruton, Rylie P Keogh, Kristy C Yuan, Kenneth Hsu, Jessica S Siegle, Nicodemus Tedla, Paul S Foster, Rakesh K Kumar.   

Abstract

The mechanisms underlying the exaggerated distal airway inflammation and hyperresponsiveness that characterize acute exacerbations of asthma are largely unknown. Using BALB/c mouse experimental models, we demonstrated a potentially important role for alveolar macrophages (AM) in the development of an allergen-induced exacerbation of asthma. To induce features of airway inflammation and remodeling characteristic of mild chronic asthma, animals were systemically sensitized and exposed to low mass concentrations (≈3 mg/m(3)) of aerosolized ovalbumin for 30 minutes per day, 3 days per week, for 4 weeks. A subsequent single moderate-level challenge (≈30 mg/m(3)) was used to trigger an acute exacerbation. In chronically challenged animals, cytokine expression by AM was not increased, whereas after an acute exacerbation, AM exhibited significantly enhanced expression of proinflammatory cytokines, including interleukin (IL) 1β, IL-6, CXCL-1, and tumor necrosis factor α. In parallel, there was a marked increase in the expression of several cytokines by CD4(+) T-lymphocytes, notably the Th2 cytokines IL-4 and IL-13. Importantly, AM from an acute exacerbation stimulated the expression of Th2 cytokines when cocultured with CD4(+) cells from chronically challenged animals, and their ability to do so was significantly greater than AM from either chronically challenged or naïve controls. Stimulation was partly dependent on interactions involving CD80/86. We conclude that in an acute exacerbation of asthma, enhanced cytokine expression by AM may play a critical role in triggering increased expression of cytokines by pulmonary CD4(+) T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724599      PMCID: PMC2947263          DOI: 10.2353/ajpath.2010.100019

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Exacerbations: the asthma paradox.

Authors:  Stephen T Holgate
Journal:  Am J Respir Crit Care Med       Date:  2005-10-15       Impact factor: 21.405

2.  Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.

Authors:  C S Murray; G Poletti; T Kebadze; J Morris; A Woodcock; S L Johnston; A Custovic
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

3.  Building a better mouse model: experimental models of chronic asthma.

Authors:  P C Fulkerson; M E Rothenberg; S P Hogan
Journal:  Clin Exp Allergy       Date:  2005-10       Impact factor: 5.018

4.  Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens.

Authors:  Fabian Blank; Barbara Rothen-Rutishauser; Peter Gehr
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

5.  Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation.

Authors:  Jessica S Siegle; Nicole Hansbro; Cristan Herbert; Ming Yang; Paul S Foster; Rakesh K Kumar
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 6.  Therapeutic significance of distal airway inflammation in asthma.

Authors:  Richard J Martin
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

7.  Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism.

Authors:  C Tang; M D Inman; N van Rooijen; P Yang; H Shen; K Matsumoto; P M O'Byrne
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

8.  Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice.

Authors:  Jeffrey R Crosby; Mausumee Guha; David Tung; Doreen A Miller; Brianna Bender; Thomas P Condon; Cathie York-DeFalco; Richard S Geary; Brett P Monia; James G Karras; Susan A Gregory
Journal:  J Pharmacol Exp Ther       Date:  2007-03-26       Impact factor: 4.030

9.  Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study.

Authors:  Rosalind M Green; Adnan Custovic; Gwen Sanderson; Jenny Hunter; Sebastian L Johnston; Ashley Woodcock
Journal:  BMJ       Date:  2002-03-30

Review 10.  Interferon-gamma as a possible target in chronic asthma.

Authors:  Rakesh K Kumar; Dianne C Webb; Cristan Herbert; Paul S Foster
Journal:  Inflamm Allergy Drug Targets       Date:  2006-12
View more
  20 in total

1.  Neuroimmune semaphorin 4A as a drug and drug target for asthma.

Authors:  G Mogie; K Shanks; E H Nkyimbeng-Takwi; E Smith; E Davila; M M Lipsky; L J DeTolla; A D Keegan; S P Chapoval
Journal:  Int Immunopharmacol       Date:  2013-08-28       Impact factor: 4.932

Review 2.  Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells.

Authors:  Wei Duan; Michael Croft
Journal:  Ann Am Thorac Soc       Date:  2014-12

3.  Alveolar macrophages modulate allergic inflammation in a murine model of asthma.

Authors:  Bo Ram Bang; Eunyoung Chun; Eun Jin Shim; Hyun Seung Lee; Soo Yeon Lee; Sang Heon Cho; Kyung Up Min; You Young Kim; Heung Woo Park
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 4.  Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.

Authors:  Paul S Foster; Steven Maltby; Helene F Rosenberg; Hock L Tay; Simon P Hogan; Adam M Collison; Ming Yang; Gerard E Kaiko; Philip M Hansbro; Rakesh K Kumar; Joerg Mattes
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

5.  Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma.

Authors:  J S Siegle; N Hansbro; C Dong; P Angkasekwinai; P S Foster; R K Kumar
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

6.  Role of Differential Estrogen Receptor Activation in Airway Hyperreactivity and Remodeling in a Murine Model of Asthma.

Authors:  Nilesh Sudhakar Ambhore; Rama Satyanarayana Raju Kalidhindi; Jagadish Loganathan; Venkatachalem Sathish
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

7.  SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice.

Authors:  Jyoti V Thaikoottathil; Richard J Martin; Peter Y Di; Maisha Minor; Stephanie Case; Bicheng Zhang; Gongyi Zhang; Hua Huang; Hong Wei Chu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-12       Impact factor: 6.914

8.  Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice.

Authors:  Nobuaki Mizutani; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 9.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

10.  Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33.

Authors:  A M Shadie; C Herbert; R K Kumar
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.